Boehringer Ingelheim (Schweiz) GmbH - Pradaxa 110 mg, Kapseln | | 61385 | | 02 | | Pradaxa 110 mg | | Kapseln | | B01AE07 | | Dabigatran Etexilate | | 29.05.2012 | | |
| Composition | dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas 126.83 mg, acaciae gummi, acidum tartaricum, hypromellosum, dimeticonum, talcum, hydroxypropylcellulosum, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 171, E 132, aqua purificata, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Dabigatranum Etexilatum | 110 mg |
| BAG: Principe actif | Concentr. |
---|
Dabigatranum Etexilatum | 110 mg |
| | Agents auxilliaires | | informations additionels |
---|
(Nigrum) | | | Acaciae Gummi | | | Acide Tartarique | | | Aqua Purificata | | | Carrageenanum | | | Dimeticone | | | E 132 | | color. | E 171 | | color. | E 172 | | color. | Hydroxypropylcellulosum | | | Hypromellosum | | Kapselhülle | Potassium Chlorure | | | Kalii Hydroxidum | | | Lacca | | Drucktinte | Pro Capsula | | | Talcum | | |
| |
| |
|